Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic angiogenesis.

A Durairaj1, A Mehra, R P Singh

  • 1Division of Cardiology, University of Southern California School of Medicine, Los Angeles, California, USA.

Cardiology in Review
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of ICAM-1 biophore to design cytoadherence blocking peptides.

Journal of molecular graphics & modelling·2015
Same author

The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.

Thrombosis and haemostasis·2014
Same author

Cryopreservation of quince (Cydonia oblonga Mill.).

Cryo letters·2014
Same author

Lead contamination of surgical gloves by contact with a lead hand.

ISRN orthopedics·2014
Same author

Infrapatellar fat pad: an aid in revision total knee arthroplasty.

Annals of the Royal College of Surgeons of England·2014
Same author

Bioavailability of iodine in the UK-Peak District environment and its human bioaccessibility: an assessment of the causes of historical goitre in this area.

Environmental monitoring and assessment·2014
Same journal

Cardiotoxicity of Antibody-Drug Conjugates in HER2-Positive Cancer: Beyond Left Ventricular Ejection Fraction Decline.

Cardiology in review·2026
Same journal

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026
Same journal

Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
Same journal

Growing Heart Valves in Congenital Cardiac Surgery: Mechanisms and Considerations for Tissue-Engineered Heart Valves, Noncryopreserved Homografts, and Partial Heart Transplantation.

Cardiology in review·2026
Same journal

Implementation Gaps and Limitations of Statin Therapy in Young Adults: Bridging Guideline Recommendations and Real-World Practice.

Cardiology in review·2026
Same journal

Cardiovascular Manifestations of Epilepsy.

Cardiology in review·2026
See all related articles

Coronary artery disease (CAD) is a major health issue. For patients unsuitable for traditional revascularization, therapeutic angiogenesis offers a promising new treatment to improve heart blood supply.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine

Background:

  • Coronary artery disease (CAD) is a leading cause of death globally.
  • Current treatments include risk factor modification, medical therapy, and revascularization procedures like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
  • A subset of patients with complex CAD are not candidates for conventional revascularization.

Purpose of the Study:

  • To introduce therapeutic angiogenesis as a novel treatment strategy.
  • To address the unmet need for treating patients with diffuse or complex coronary artery disease unsuitable for standard revascularization.
  • To highlight the potential of therapeutic angiogenesis in improving myocardial blood supply and alleviating symptoms.

Main Methods:

  • Review of current treatment approaches for coronary artery disease.

Related Experiment Videos

  • Analysis of patient populations unsuitable for PCI or CABG.
  • Introduction of therapeutic angiogenesis as an emerging medical technology.

    • Main Results:

    • Approximately 12% of patients in a tertiary referral center analysis were unsuitable for revascularization.
    • The number of patients ineligible for revascularization is projected to increase.
    • Therapeutic angiogenesis presents a potential solution for this growing patient group.

    Conclusions:

    • Therapeutic angiogenesis offers a promising new avenue for treating ischemic heart disease.
    • This approach aims to improve blood flow to the heart muscle in patients with limited treatment options.
    • It holds potential for symptomatic relief in a significant and expanding patient population.